JP2016533332A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016533332A5 JP2016533332A5 JP2016516958A JP2016516958A JP2016533332A5 JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5 JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016516958 A JP2016516958 A JP 2016516958A JP 2016533332 A5 JP2016533332 A5 JP 2016533332A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nanoparticle
- self
- amino acid
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361881848P | 2013-09-24 | 2013-09-24 | |
| US61/881,848 | 2013-09-24 | ||
| PCT/US2014/057240 WO2015048149A1 (en) | 2013-09-24 | 2014-09-24 | Self-assembled nanoparticle vaccines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016533332A JP2016533332A (ja) | 2016-10-27 |
| JP2016533332A5 true JP2016533332A5 (enExample) | 2017-11-02 |
Family
ID=51662365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016516958A Ceased JP2016533332A (ja) | 2013-09-24 | 2014-09-24 | 自己集合型ナノ粒子ワクチン |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20150110825A1 (enExample) |
| EP (1) | EP3049107A1 (enExample) |
| JP (1) | JP2016533332A (enExample) |
| CA (1) | CA2925201A1 (enExample) |
| WO (1) | WO2015048149A1 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9630994B2 (en) | 2014-11-03 | 2017-04-25 | University Of Washington | Polypeptides for use in self-assembling protein nanostructures |
| WO2016122414A1 (en) * | 2015-01-29 | 2016-08-04 | Agency For Science, Technology And Research | Nanocapsules carrying chikungunya-associated peptides |
| US20190022210A1 (en) * | 2015-11-06 | 2019-01-24 | Victor G. Solodushko | Novel platform dna vaccine |
| WO2017081082A2 (en) * | 2015-11-09 | 2017-05-18 | Curevac Ag | Optimized nucleic acid molecules |
| WO2018005558A1 (en) | 2016-06-27 | 2018-01-04 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Self-assembling insect ferritin nanoparticles for display of co-assembled trimeric antigens |
| TWI634899B (zh) * | 2016-11-22 | 2018-09-11 | 國立臺灣大學 | 包含類ｂ肝病毒顆粒作為佐劑的疫苗組成物 |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| ES3040563T3 (en) * | 2017-04-04 | 2025-11-03 | Univ Washington | Self-assembling protein nanostructures displaying paramyxovirus and/or pneumovirus f proteins and their use |
| PT3661968T (pt) | 2017-08-04 | 2022-07-04 | Governing Council Univ Toronto | Plataforma de nanopartículas para administração de anticorpos e vacinas |
| WO2019135086A1 (en) * | 2018-01-06 | 2019-07-11 | Emergex Vaccines Holding Limited | Mhc class i associated peptides for prevention and treatment of multiple flavi virus |
| CN112088014A (zh) | 2018-02-28 | 2020-12-15 | 华盛顿大学 | 自组装纳米结构疫苗 |
| US20220017881A1 (en) * | 2018-06-08 | 2022-01-20 | Modalis Therapeutics Corporation | MODIFIED Cas9 PROTEIN AND USE THEREOF |
| KR102076917B1 (ko) * | 2018-10-25 | 2020-02-13 | 연세대학교 산학협력단 | 자가조립 나노 입자를 제조하기 위한 유전자 재조합 발현 벡터 시스템 및 이를 이용하는 방법 |
| EP4004018A1 (en) | 2019-07-24 | 2022-06-01 | GlaxoSmithKline Biologicals SA | Modified human cytomegalovirus proteins |
| CN112439056B (zh) * | 2019-08-28 | 2022-05-31 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的o型口蹄疫疫苗和应用 |
| EP4161570A1 (en) | 2020-06-05 | 2023-04-12 | GlaxoSmithKline Biologicals S.A. | Modified betacoronavirus spike proteins |
| EP4469078A1 (en) | 2022-01-28 | 2024-12-04 | GlaxoSmithKline Biologicals S.A. | Modified human cytomegalovirus proteins |
| CN116143949A (zh) * | 2023-02-23 | 2023-05-23 | 中山大学 | 一种水痘-带状疱疹病毒疫苗及其制备方法 |
| CN117567652B (zh) * | 2024-01-19 | 2024-05-14 | 北京安百胜生物科技有限公司 | 一种重组呼吸道合胞病毒颗粒抗原 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR050693A1 (es) * | 2004-08-11 | 2006-11-15 | Zheng Xin Xiao | Composiciones que contienen interleuquina-15 mutante y supresion de una respuesta inmune. |
| WO2009033004A1 (en) * | 2007-09-07 | 2009-03-12 | Montana State University | Protein cages and their uses |
| PT2222710T (pt) * | 2007-12-24 | 2016-11-02 | Glaxosmithkline Biologicals Sa | Antigénios de rsv recombinantes |
| WO2010075491A2 (en) * | 2008-12-24 | 2010-07-01 | University Of Rochester | Recombinant expression of self-folding neutralizing epitope-bearing subdomains of the respiratory syncytial virus attachment and fusion proteins |
| PT2707385T (pt) * | 2011-05-13 | 2017-12-19 | Glaxosmithkline Biologicals Sa | Antigénios de f de rsv pré-fusão |
| US20130049342A1 (en) * | 2011-08-25 | 2013-02-28 | James Michael Cottrell | Trailer chassis hold down system |
| CN103957891B (zh) * | 2011-09-23 | 2017-01-11 | 美利坚合众国由健康及人类服务部部长代表 | 基于流感血凝素蛋白的新颖疫苗 |
| EP2760469A4 (en) * | 2011-09-30 | 2015-03-18 | Novavax Inc | RECOMBINANT RSV-F NANOPARTICLE VACCINE AGAINST RESPIRATORY SYNZYTIAL VIRUS |
| RU2761631C2 (ru) * | 2013-03-13 | 2021-12-13 | Дзе Юнайтед Стэйтс Оф Америка, Эс Репрезентед Бай Дзе Секретэри, Департмент Оф Хелт Энд Хьюман Сервисиз | Белки rsv в предшествующей слиянию конформации и их применение |
-
2014
- 2014-09-24 JP JP2016516958A patent/JP2016533332A/ja not_active Ceased
- 2014-09-24 CA CA2925201A patent/CA2925201A1/en not_active Abandoned
- 2014-09-24 WO PCT/US2014/057240 patent/WO2015048149A1/en not_active Ceased
- 2014-09-24 US US14/495,640 patent/US20150110825A1/en not_active Abandoned
- 2014-09-24 EP EP14781401.6A patent/EP3049107A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016533332A5 (enExample) | ||
| JP2015509707A5 (enExample) | ||
| JP2022023102A (ja) | 新規多価ナノ粒子に基づくワクチン | |
| Patterson et al. | Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza | |
| JP2015501840A5 (enExample) | ||
| US20130236491A1 (en) | Spherical nano and microparticles derived from plant viruses for the display of foreign proteins or epitopes | |
| JP2015508284A5 (enExample) | ||
| JP2014500724A5 (enExample) | ||
| JP2016501829A5 (enExample) | ||
| JP2014507146A5 (enExample) | ||
| JP2012509071A5 (enExample) | ||
| JP2019506175A5 (enExample) | ||
| JP2012501959A5 (enExample) | ||
| JP2014502156A5 (enExample) | ||
| Mao et al. | Surface display on lactic acid bacteria without genetic modification: strategies and applications | |
| CN117534735A (zh) | 腺病毒外壳蛋白衍生递送载体 | |
| JP2012515557A5 (enExample) | ||
| JP2018524019A5 (enExample) | ||
| JP2010538619A5 (enExample) | ||
| JP2014519817A5 (enExample) | ||
| Lee et al. | Nanoglue: an alternative way to display cell-internalizing peptide at the spikes of hepatitis B virus core nanoparticles for cell-targeting delivery | |
| WO2022043449A1 (en) | Vaccines based on an antigen protein fused to a nanostructuring scaffold | |
| JP2019502404A5 (enExample) | ||
| CN107344969B (zh) | 一种纳米流感疫苗及构建方法和应用 | |
| JP2018505135A (ja) | ヤツメウナギ由来の配列への融合による組換えタンパク質の多量体化 |